News

March 19, 2019

Nativis Announces Name Change To EMulate Therapeutics, Inc.

Read More

February 26, 2019

How far will the Voyager® take us?

Read More

February 19, 2019

Nativis Announces Additional Publication of Further Study in Patients with Recurrent Glioblastoma (rGBM)

Read More

December 18, 2018

Nativis Announces Publication of Study in Patients with Recurrent Glioblastoma (rGBM)

Read More

November 14, 2018

Nativis Announces Early Data from Study in Treatment of Patients with Newly Diagnosed Glioblastoma

Read More

August 8, 2018

Nativis Appoints Andrew Daniels to Board of Directors

Read More

July 5, 2018

Nativis Research Partner Presents at the International Symposium on Pediatric Neuro-Oncology Annual Meeting in Denver

Read More

April 18, 2018

FDA Grants Third Humanitarian Use Device Designation for Nativis Voyager® Pediatric System

Read More

April 5, 2018

FDA Grants Humanitarian Use Designation for Nativis Voyager® Pediatric System In Medulloblastoma

Read More

March 22, 2018

Nativis to Present at 17th Annual Needham & Co. Healthcare Conference

Read More

Older »